Role of MEK1 and DIAPH3 Expression in Colorectal Carcinoma
Foda, A., Ahmed, M., Elkalla, H., El-Zahaf, E., Abdallah, H., Wagih, H., Sami, M. (2018). Role of MEK1 and DIAPH3 Expression in Colorectal Carcinoma. EKB Journal Management System, 14(2), 75-82. doi: 10.21608/resoncol.2018.4042.1059
Abd AlRahman M. Foda; Mohamed A. H. Ahmed; Hend M. H. R. Elkalla; Eman El-Zahaf; Heba Abdallah; Heba M. Wagih; Manal M. Sami. "Role of MEK1 and DIAPH3 Expression in Colorectal Carcinoma". EKB Journal Management System, 14, 2, 2018, 75-82. doi: 10.21608/resoncol.2018.4042.1059
Foda, A., Ahmed, M., Elkalla, H., El-Zahaf, E., Abdallah, H., Wagih, H., Sami, M. (2018). 'Role of MEK1 and DIAPH3 Expression in Colorectal Carcinoma', EKB Journal Management System, 14(2), pp. 75-82. doi: 10.21608/resoncol.2018.4042.1059
Foda, A., Ahmed, M., Elkalla, H., El-Zahaf, E., Abdallah, H., Wagih, H., Sami, M. Role of MEK1 and DIAPH3 Expression in Colorectal Carcinoma. EKB Journal Management System, 2018; 14(2): 75-82. doi: 10.21608/resoncol.2018.4042.1059

Role of MEK1 and DIAPH3 Expression in Colorectal Carcinoma

Research in Oncology
Article 6, Volume 14, Issue 2, December 2018, Page 75-82  XML PDF (598.82 K)
Document Type: Original Article
DOI: 10.21608/resoncol.2018.4042.1059
View on SCiNiTO View on SCiNiTO
Authors
Abd AlRahman M. Foda1; Mohamed A. H. Ahmed2, 3; Hend M. H. R. Elkalla email orcid 4; Eman El-Zahaf4; Heba Abdallah5; Heba M. Wagih2; Manal M. Sami2
1Pathology Department, Faculty of Medicine, Mansoura University, Mansoura, Egypt
2Pathology Department, Faculty of Medicine, Suez Canal University, Ismailia, Egypt
3Department of Pathology, East Sussex Health Care Trust, United Kingdom
4Clinical Oncology and Nuclear Medicine Department, Faculty of Medicine, Mansoura University, Mansoura, Egypt
5Medical Oncology, Mit Ghamr Cancer Centre, Mit Ghamr, Egypt
Abstract
Background: Colorectal carcinoma (CRC) is one of the serious causes of morbidity and mortality worldwide. It is characterized by activating mutations in genes encoding Receptor Tyrosine Kinases (RAS, RAF, MEK1 or MEK2) which act as driving oncogenes. DIAPH3 deficiency has been reported to enhance cancer cell motility, invasion and metastasis and also correlates with aggressive behaviour of cancer.
Aim: To study the overexpression of MEK1 and DIAPH3 in CRC patients and their prognostic significance.
Methods: We examined the immunohistochemical expression of MEK1 and DIAPH3 using tissue microarray technique in 150 CRC specimens divided into two groups. The mucinous group (MG) included specimens of 56 mucinous adenocarcinoma and 19 signet ring cell carcinoma, while the non-mucinous group (NMG) included 75 non-mucinous adenocarcinoma specimens for comparison.
Results: MEK1 and DIAPH3 were strongly expressed in >50% of the studied specimens. The positivity of MEK1 expression was significantly higher in NMG compared to MG (66.7% and 34.3%, respectively; p < 0.001). In all cases, the overexpression of MEK1 was significantly associated with peri-tumoral and intra-tumoral lymphocytic response (p=0.005 and 0.008, respectively). Furthermore, MEK1 overexpression showed statistically significant correlation with better OS (p=0.023) in the whole group of patients. The expression of DIAPH-3 did not differ significantly between NMG and MG (53.3% and 47.1%, respectively; p=0.456). There was strong relation between the overexpression of MEK1 and DIAPH3 (p < 0.001).
Conclusion: The results suggest a potential synergistic role of MEK1 and DIAPH3 overexpression and the development of CRC. Further large scale studies are warranted.
Keywords
colorectal cancer; Mucinous adenocarcinoma; MEK1; DIAPH3; TMA
Statistics
Article View: 620
PDF Download: 669